NET LOSS PER SHARE. Basic and diluted net loss per share is computed using the weighted average number of common shares outstanding during the period, less outstanding nonvested shares. Outstanding nonvested shares are not included in the computation of basic and diluted net loss per share until the time-based vesting restriction has lapsed. However, for the purposes of computing diluted earnings per share in periods with a profit, the dilutive effect of outstanding nonvested shares would be included using the treasury stock method. The Company has other securities outstanding that could dilute basic earnings per share in the future that were not included in the computation of diluted net loss per share in the periods presented as their effect is antidilutive. For additional disclosures regarding potentially dilutive stock options, warrants, nonvested shares and convertible debentures, see Notes 4 and 7. The following table sets forth the computation of basic and diluted net loss per share (in thousands, except per share amounts): 2000 1999 1998 ------- -------- -------- Numerator for basic and diluted net loss per share: Net loss.......................................... $(6,293) $(21,399) $(40,658) ======= ======== ======== Denominator: Weighted-average common shares.................... 26,046 25,403 25,082 Weighted-average nonvested shares subject to repurchase..................................... (680) (1,142) (1,585) ------- -------- -------- Denominator for basic and diluted net loss per share............................................. 25,366 24,261 23,497 ======= ======== ======== Basic and diluted net loss per share................ $ (0.25) $ (0.88) $ (1.73) ======= ======== ======== 41 44 HEARTPORT, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
NET LOSS PER SHARE. (66,000)----------- 213,000 ----------- $(5,717,000) =========== $ (.66) (62,000)------------ 616,000 ------------ $ (9,917,000) ============ $ (.98) (32,000) (251,000) ------------ ------------ 644,000 2,001,000 ------------ ------------ $(14,288,000) $(41,313,000) ============ ============ $ (1.26) =========== Weighted average number ============ ============ equivalent shares outstanding 8,644,000 10,103,000 11,315,000 =========== ============ ============ of common and common The accompanying notes are an integral part of these financial statements. 41 AASTROM BIOSCIENCES, INC. (A DEVELOPMENT STAGE COMPANY) STATEMENTS OF SHAREHOLDERS' EQUITY DEFECIT UNREALIZED ACCUMULATED GAIN TOTAL PREFERRED STOCK COMMON STOCK DURING THE SHAREHOLDER STOCK (LOSSES) SHARE- ------------------------- ------------------------- DEVELOPMENT NOTES PURCHASE ON HOLDERS' SHARES AMOUNT SHARES AMOUNT STAGE RECEIVABLE RIGHTS INVESTMENTS EQUITY ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ BALANCE, MARCH 24, 1989 (Inception)... -- $ -- -- $ -- $ -- $ -- $ -- $ -- $ -- Non--cash issuance of Common Stock.. 454,545 -- -- Issuance of Series A Preferred Stock at $1.00 per share in August 1989... 1,500,000 1,500,000 1,500,000 Issuance of Series A Preferred Stock in March 1991 at $1.00 per share, net of issuance costs of $5,000.... 1,000,000 995,000 995,000 Issuance of Series B Preferred Stock in April 1992 at $2.00 per share, net of issuance costs of $46,000..... 3,030,000 6,014,000 6,014,000 Issuance of Common Stock for services... 33,333 10,000 10,000 Issuance of Series C Preferred Stock in October 1993 at $1,000 per share, net of issuance costs of $175,000.... 10,000 9,825,000 9,825,000 Exercise of stock options.. 1,229,482 230,000 (198,000) 32,000 Net loss........ (11,391,000) (11,391,000) ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ BALANCE, JUNE 30, 1994....... 5,540,000 18,334,000 1,717,360 240,000 (11,391,000) (198,000) -- -- 6,985,000 Issuance of Series D Preferred Stock in April and May 1995 at $4.00 per share, net of issuance costs of $81,000........ 2,500,001 9,919,000 9,919,000 Exercise of stock options........ 39,103 8,000 8,000 Retirement of Common Shares outstanding.... (25,000) (7,000) (7,000) Unrealized loss on investments. (2,000) (2,000) Net loss........ (5,717,000) (5,717,000) ------------ ------------ ------------ ------------...
NET LOSS PER SHARE. Basic net loss per common share (“Basic EPS’’) excludes dilution and is computed by dividing net loss by the weighted average number of common shares outstanding during the year. Diluted net loss per common share (“Diluted EPS’’) reflects the potential dilution that could occur if stock options or other contracts to issue shares of common stock were exercised or converted into common stock. The computation of Diluted EPS does not assume exercise or conversion of securities that would have an anti-dilutive effect on net loss per common share 2019 2018 Numerator Net loss applicable to common shareholders $ (5,135,731 ) $ (3,823,913 ) Denominator Weighted average number of common shares outstanding 42,154,948 36,108,948 Net loss per share (basic and diluted) $ (0.12 ) $ (0.11 )
NET LOSS PER SHARE. In February 1997 the Financial Accounting Standards Board issued Statement No. 128, "Earnings Per Share," which is required to be adopted after December 31, 1997. Statement No. 128 supersedes Accounting Principles Board Opinion No.
NET LOSS PER SHARE. 13,028,377 ============= $ (0.37) ============= ------------- 7,772,268 ============= $ (0.70) ============= ------------- 11,451,710 ============= $ (0.92) ============= ------------ 7,770,280 ============ $ (0.98) ============ <ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM JUNE 30, 1997 10Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <PERIOD-TYPE> <FISCAL-YEAR-END> <PERIOD-START> <PERIOD-END> 6-MOS DEC-31-1996 JAN-01-1997 JUN-30-1997 <CASH> 3,326,226 <SECURITIES> 44,590,786 <RECEIVABLES> 0 <ALLOWANCES> 0 <INVENTORY> 0 <CURRENT-ASSETS> 50,817,590 <PP&E> 12,432,275 <DEPRECIATION> 6,979,899 <TOTAL-ASSETS> 56,490,454 <CURRENT-LIABILITIES> 5,746,974 <BONDS> 1,389,041 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 134,038,835 <OTHER-SE> (84,684,396) <TOTAL-LIABILITY-AND-EQUITY> 56,490,454 <SALES> 0 <TOTAL-REVENUES> 5,266,980 <CGS> 0 <TOTAL-COSTS> 0 <OTHER-EXPENSES> 16,759,695 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 205,903 <INCOME-PRETAX> (10,516,049) <INCOME-TAX> 0 <INCOME-CONTINUING> (10,516,049) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (10,516,049) <EPS-PRIMARY> (1.15)
NET LOSS PER SHARE. Under SFAS No. 128, Earnings Per Share, basic and diluted loss per share is based on net loss for the relevant period, divided by the weighted average number of common shares outstanding during the period. Diluted earnings per share gives effect to all potential dilutive common shares outstanding during the period such as options, warrants, convertible preferred stock, and contingently issuable shares. Diluted net loss per share has not been presented separately as, due to the Company's net loss position, it is anti-dilutive. Had the Company been in a net income position at March 31, 2000, shares used in calculating diluted earnings per share would have included the dilutive effect of an additional 5,322,329 stock options, 2,155,715 preferred shares, placement unit options for 986,898 shares and 977,207 warrants.
NET LOSS PER SHARE. The computation of net loss per share of common stock is based on the weighted average number of shares outstanding during the period.
NET LOSS PER SHARE. As discussed in Note 1, net loss per share is calculated in accordance with SFAS No. 128. The following table reconciles the numerator and denominator for the calculation. 2000 ------------ 1999 ------------ 1998 ------------ Numerator: Net loss from continuing operations............... $(50,747,169) $(31,662,241) $(16,358,451) Preferred stock dividends......................... -- (1,562,277) (1,451,359) Accretion of Redeemable Convertible Series B Preferred Stock................................. -- (1,252,569) (481,270) ------------ ------------ ------------ (50,747,169) (34,477,087) (18,291,080) Loss from discontinued operations................. (11,203,525) (1,971,196) -- ------------ ------------ ------------ Net loss available to common shareholders......... $(61,950,694) $(36,448,283) $(18,291,080) ============ ============ ============ Denominator: Weighted average basic and diluted shares outstanding..................................... 26,105,610 21,052,614 8,575,128 ============ ============ ============ Net loss per share-basic and diluted Continuing operations............................. $ (1.94) $ (1.64) $ (2.13) Discontinued operations........................... (0.43) (0.09) -- ------------ ------------ ------------ Net loss.......................................... $ (2.37) $ (1.73) $ (2.13) ============ ============ ============ Outstanding options of 3,276,326, 2,688,980 and 1,497,286 for the periods ended December 31, 2000, 1999 and 1998, respectively, have been excluded from the above calculations as they were antidilutive.
NET LOSS PER SHARE. Pro forma net loss attributable to common stockholders as originally reported for the six month ended June 30,2022 is adjusted for the pro forma impacts of the Acquisition. Basic and diluted weighted average shares outstanding as originally reported are adjusted to reflect the effects of the issuance of 2,639,531 shares of common stock to the Sellers as of January 1, 2022.
NET LOSS PER SHARE. The Company calculated net loss per share in accordance with ASC 260, Earnings per Share. Basic earnings per share (“EPS”) is calculated by dividing the net income or loss by the weighted average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted EPS is computed by dividing the net income or loss by the weighted average number of common shares outstanding for the period and the weighted average number of dilutive common stock equivalents outstanding for the period determined using the treasury stock method. The following table sets forth potential shares of common stock that are not included in the calculation of diluted net loss per share because to do so would be anti-dilutive as of the end of each period presented: (in thousands) March 31, 2012 2011 Stock options outstanding 5,541 5,332 Warrants to purchase common stock 1,053 1,972 Unvested restricted stock 456 537 Total 7,050 7,841 Recent Accounting Pronouncements In June 2011, the Financial Accounting Standards Board issued new accounting guidance related to the presentation of comprehensive income that increases comparability between U.S. generally accepted accounting principles and International Financial Reporting Standards. This guidance will require companies to present the components of net income and other comprehensive income (“OCI”) either as one continuous statement or as two consecutive statements, eliminating the option to present components of other comprehensive income as part of the statement of changes in stockholders’ equity. This guidance is effective for the Company’s interim and annual periods beginning January 1, 2012. The Company early adopted this guidance in 2011 and reports OCI in a separate statement. The adoption did not have a material impact on the Company’s results of operations or financial position.
